Clinical Trial Update: Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes Radiprodil in Phase 1/2 studies evaluating safety, tolerability, pharmacokinetics, and its effect on seizures and behaviora…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Cortical Dysplasia
• Tuberous Sclerosis Complex

Drugs mentioned

• Radiprodil (Radiprodil)

Snippet

Sponsor: GRIN Therapeutics, Inc. | Conditions: Tuberous Sclerosis Complex, Focal Cortical Dysplasia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING